Literature DB >> 20386907

Normalization of 2-week postoperative parathyroid hormone values in patients with primary hyperparathyroidism: four-gland exploration compared to focused-approach surgery.

Peter J Mazzaglia1, Mira Milas, Eren Berber, Alan Siperstein, Jack M Monchik.   

Abstract

BACKGROUND: Elevation of parathyroid hormone (PTH) levels is commonly seen in patients with primary hyperparathyroidism (PHPT) who have undergone parathyroidectomy. This study evaluates differences in 2-week postoperative PTH levels in patients having focused-approach surgery versus four-gland exploration.
METHODS: Over 6 years, patients at Rhode Island Hospital (RIH) and the Cleveland Clinic (CCF) who had PHPT and underwent localization studies suggestive of single adenoma were analyzed. At RIH patients underwent focused-approach surgery, and at CCF routine four-gland exploration was performed. Postoperative calcium supplementation was routine at RIH and selective at CCF.
RESULTS: There were 308 patients at RIH and 370 at CCF. They were similar in age (59.2 +/- 13.0 years at RIH and 60.4 +/- 12.9 years at CCF), and sex (76.9 and 80.0% female at RIH and CCF, respectively). The mean preoperative serum calcium measured 10.9 +/- 0.7 mg/dl at RIH and 11.1 +/- 0.7 mg/dl at CCF (P < 0.001). Preoperative PTH values were similar, measuring 143.8 +/- 104.8 pg/ml in the focused-approach group (RIH) and 157.6 +/- 150.3 pg/ml in the four-gland exploration group (CCF). Preoperative 25-hydroxyvitamin D (vitamin D-25) levels were 24.1 +/- 12.0 ng/ml at RIH and 27.4 +/- 10.6 ng/ml at CCF; and the prevalence of vitamin D-25 deficiency (level <20 ng/ml) was 43.9% at RIH and 27% at CCF (P = 0.017). The proportion of patients whose intraoperative PTH value dropped by >or=50% prior to completion of surgery was 95.0% at RIH and 95.5% at CCF. The total gland weight resected per patient was 942 mg at RIH versus 1,394 mg at CCF (P = 0.003). The 2-week postoperative serum PTH was >65 pg/ml in 18.8% at RIH and in 38.7% at CCF (P < 0.001). The 2-week postoperative serum calcium values dropped to 9.2 +/- 0.6 mg/dl at RIH and to 9.5 +/- 0.8 mg/dl at CCF (P < 0.001). The incidence of multigland disease was 5.8% at RIH and 21.9% at CCF (P <or= 0.001).
CONCLUSIONS: Among patients with PHPT who underwent a localizing study indicating unilateral disease, a significant proportion had eucalcemic PTH elevation 2 weeks after parathyroidectomy. The elevation was more frequent in the four-gland exploration group and correlated most strongly with greater adenoma mass.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20386907     DOI: 10.1007/s00268-010-0557-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  31 in total

1.  25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy.

Authors:  Zoe A Stewart; Amanda Blackford; Helina Somervell; Kent Friedman; Elizabeth Garrett-Mayer; Alan P B Dackiw; Martha A Zeiger
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

2.  Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism.

Authors:  J L Pasieka; L L Parsons
Journal:  World J Surg       Date:  1998-06       Impact factor: 3.352

3.  Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial.

Authors:  Anders Bergenfelz; Pia Lindblom; Sten Tibblin; Johan Westerdahl
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

4.  Risk factors for postoperative hypocalcemia after surgery for primary hyperparathyroidism.

Authors:  J Westerdahl; P Lindblom; S Valdemarsson; S Tibblin; A Bergenfelz
Journal:  Arch Surg       Date:  2000-02

5.  Patients with elevated serum parathyroid hormone levels after parathyroidectomy: showing signs of decreased peripheral parathyroid hormone sensitivity.

Authors:  Erik Nordenström; Johan Westerdahl; Anders Isaksson; Pia Lindblom; Anders Bergenfelz
Journal:  World J Surg       Date:  2003-02       Impact factor: 3.352

6.  Parathyroid hormone: before and after parathyroidectomy.

Authors:  Q Y Duh; C D Arnaud; K E Levin; O H Clark
Journal:  Surgery       Date:  1986-12       Impact factor: 3.982

7.  Parathyroid metabolism after operative treatment of hypercalcemic (primary) hyperparathyroidism.

Authors:  G L Irvin; D J Newell; S D Morgan
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

Review 8.  Primary hyperparathyroidism: a current perspective.

Authors:  Ronald A DeLellis; Peter Mazzaglia; Shamlal Mangray
Journal:  Arch Pathol Lab Med       Date:  2008-08       Impact factor: 5.534

9.  Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.

Authors:  Todd D Beyer; Carmen C Solorzano; Richard A Prinz; Ambika Babu; Naris Nilubol; Subhash Patel
Journal:  Surgery       Date:  2007-04-26       Impact factor: 3.982

10.  Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management.

Authors:  Elizabeth A Mittendorf; James I Merlino; Christopher R McHenry
Journal:  Am Surg       Date:  2004-02       Impact factor: 0.688

View more
  5 in total

Review 1.  Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review.

Authors:  Roberto de la Plaza Llamas; José Manuel Ramia Ángel; Vladimir Arteaga Peralta; Cristina García Amador; Aylhín Joana López Marcano; Aníbal Armando Medina Velasco; Begoña González Sierra; Alba Manuel Vázquez; Raquel Aránzazu Latorre Fragua
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-05       Impact factor: 2.503

2.  Persistently Elevated PTH After Parathyroidectomy at One Year: Experience in a Tertiary Referral Center.

Authors:  Marie Caldwell; Jeff Laux; Marshall Clark; Lawrence Kim; Janet Rubin
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

3.  Robotic surgery for primary hyperparathyroidism.

Authors:  Georgios Karagkounis; Duygu Derya Uzun; David P Mason; Sudish C Murthy; Eren Berber
Journal:  Surg Endosc       Date:  2014-04-26       Impact factor: 4.584

4.  Eucalcemic parathyroid hormone elevation after parathyroidectomy for primary sporadic hyperparathyroidism: risk factors, trend, and outcome.

Authors:  Brian Hung-Hin Lang; Ian Yu-Hong Wong; Kai Pun Wong; Chung-Yau Lo
Journal:  Ann Surg Oncol       Date:  2011-07-06       Impact factor: 5.344

Review 5.  Parathyroidectomy: is vitamin D a player for a good outcome?

Authors:  M Carsote; D N Paduraru; A E Nica; A Valea
Journal:  J Med Life       Date:  2016 Oct-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.